
Celcuity
Clinical-stage biotechnology company that seeks to extend the lives of cancer patients by pursuing an integrated therapeutic and companion diagnostic strategy.
Market cap
$474m
Enterprise value
$367m
Share price
$13.35 CELC
Authorizing premium user...